Published

CCH attack frequency reduction after psilocybin correlates with hypothalamic functional connectivity.

An abstract is available from the original source but is not redistributed by this tracker. Read the source record.

Open source BibTeX RIS

Bibliographic context

Journal: Headache
Date: 2024-01-01
Source: PubMed
DOI: 10.1111/head.14656
PubMed: 38238974

Authors

Madsen MK Petersen AS Stenbaek DS Sørensen IM Schiønning H Fjeld T Nykjaer CH Larsen SMU Grzywacz M Mathiesen T Klausen IL Overgaard-Hansen O Brendstrup-Brix K Linnet K Johansen SS Fisher PM Jensen RH Knudsen GM

Watch author

Derived topics and classifications

psilocybin psilocin Headache / Migraine Brain Imaging Mechanism of Action Aging Clinical Trial Clinical Trial

Citation graph

0 referenced DOIs found in stored source metadata. 4 indexed papers cite this DOI.

Open citation network

Indexed papers citing this DOI

Effects of psilocybin on sleep quality and brain microstructure in chronic cluster headache2026-05-29 Pilot study of psilocybin in patients with post-treatment lyme disease2026-02-25 Addressing a major interference in the quantification of psilocin in mouse plasma: Development of a validated liquid chromatography tandem mass spectrometry method2024-08-01 CCH attack frequency reduction after psilocybin correlates with hypothalamic functional connectivity.2024-01-01

Related papers

Prophylactic Effects of Psilocybin on Chronic Cluster Headache: an Open-label Clinical Trial and Neuroimaging StudyClinicalTrials.gov · 2022-08-10 Comparing single- and repeat-dose psilocybin with active placebo for migraine prevention in an exploratory randomized controlled clinical trial.Headache · 2026-04-01 Patient perspectives on research gaps in cluster headache.Headache · 2026-02-01 Plain Language Summary Publication: Low-dose psilocybin in short-lasting unilateral neuralgiform headache attacks: Results from an open-label phase Ib ascending dose studyHeadache The Journal of Head and Face Pain · 2024-10-09 Low-dose psilocybin in short-lasting unilateral neuralgiform headache attacks: results from an open-label phase Ib ascending dose study.Headache · 2024-01-01 Ergotamine enhances circadian amplitude and diurnally mitigates nitroglycerin-induced mechanical hypersensitivity.The journal of headache and pain · 2025-05-23 Safety and Efficacy of Psilocybin for the Treatment of Headache DisordersClinicalTrials.gov · 2023-12-15 Exploratory investigation of a patient-informed low-dose psilocybin pulse regimen in the suppression of cluster headache: Results from a randomized, double-blind, placebo-controlled trial.Headache · 2022-11-01